1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
- 2008
- Long Term Efficacy And Tolerability Of Anagrelide In Myeloproliferative Disorders
- 2005
- Management of patients with polycythaemia vera: results of a survey among Swedish haematologists
- Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up
- 2004
- Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders
- Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
- 2003
- Mutated V-H genes and preferential V(H)3-21 use define new subsets of mantle cell lymphoma
- A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor: significant effects on quality of life
- 2002
- Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group